Monte Rosa Therapeutics, Inc. (GLUE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:03AM EDT. Market open.
| Previous Close | 5.94 |
| Open | 5.93 |
| Bid | 5.50 x 100 |
| Ask | 5.73 x 300 |
| Day's Range | 5.53 - 5.93 |
| 52 Week Range | 2.44 - 8.84 |
| Volume | |
| Avg. Volume | 137,065 |
| Market Cap | 280.863M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.63 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.50 |
ZacksRecent Price Trend in Monte Rosa Therapeutics (GLUE) is Your Friend, Here's Why
Monte Rosa Therapeutics (GLUE) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
ZacksDoes Monte Rosa Therapeutics (GLUE) Have the Potential to Rally 107.79% as Wall Street Analysts Expect?
The consensus price target hints at a 107.8% upside potential for Monte Rosa Therapeutics (GLUE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ZacksMonte Rosa Therapeutics (GLUE) Is a Great Choice for 'Trend' Investors, Here's Why
Monte Rosa Therapeutics (GLUE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.